Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response

Behavioural Brain Research

Volumn 217, Issue 1, 2011, Pages 1-9

  Fendt, Markus ^a   Buchi, Mélanie ^a   Bürki, Hugo ^a   Imobersteg, Stefan ^a   Ricoux, Bérangère ^a   Suply, Thomas ^a   Sailer, Andreas W ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Acoustic startle response; Anxiety; Circadian rhythm; Fear; Freezing; Prepulse inhibition

Indexed keywords

COCAINE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONDITIONING; CONTROLLED STUDY; FEAR; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HYPERACTIVITY; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; COCAINE; CONDITIONING, CLASSICAL; IMMOBILITY RESPONSE, TONIC; INFUSIONS, INTRAVENTRICULAR; INHIBITION (PSYCHOLOGY); MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; STARTLE REACTION;

EID: 78149263561     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.09.022     Document Type: Article

References (35)

1. Abramov U., Puussaar T., Raud S., Kurrikoff K., Vasar E. Behavioural differences between C57BL/6 and 129S6/SvEv strains are reinforced by environmental enrichment. Neurosci Lett 2008, 443:223-227.
2. Allen I.C., Pace A.J., Jania L.A., Ledford J.G., Latour A.M., Snouwaert J.N., et al. Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease. Am J Physiol-Lung Cell Mol Physiol 2006, 291:L1005-L1017.
3. Badia-Elder N.E., Henderson A.N., Bertholomey M.L., Dodge N.C., Stewart R.B. The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats. Alcohol Clin Exp Res 2008, 32:1380-1387.
4. Beraki S., Diaz-Heijtz R., Tai F., Ogren S.O. Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice. Int J Neuropsychopharmacol 2009, 12:243-255.
5. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001, 156:234-258.
6. Bremner J.D. Brain imaging in anxiety disorders. Expert Rev Neurotherap 2004, 4:275-284.
7. Camp M., Norcross M., Whittle N., Feyder M., D'Hanis W., Yilmazer-Hanke D., et al. Impaired Pavlovian fear extinction is a common phenotype across genetic lineages of the 129 inbred mouse strain. Genes Brain Behav 2009, 8:744-752.
8. Cannella N., Economidou D., Kallupi M., Stopponi S., Heilig M., Massi M., et al. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 2009, 34:2125-2134.
9. Castro A.A., Moretti M., Casagrande T.S., Martinello C., Petronilho F., Steckert A.V., et al. Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. Pharmacol Biochem Behav 2009, 91:636-642.
10. Davis M. Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 2006, 61:741-756.
11. Domschke K, Reif A, Weber H, Richeter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauka B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Gerlach AL, Kircher T, Lang T, Alpers GW, Ströhle A, Fehm L, Gloster AT, Wittchen H-U, Arolt V, Pauli P, Hamm A, Deckert J. Neuropeptide S receptor gene-converging evidence for a role in panic disorder. Mol Psychiatry; in press.
12. Duangdao D.M., Clark S.D., Okamura N., Reinscheid R.K. Behavioral phenotyping of neuropeptide S receptor knockout mice. Behav Brain Res 2009, 205:1-9.
13. Endres T., Widmann K., Fendt M. Are rats predisposed to learn 22kHz calls as danger-predicting signals?. Behav Brain Res 2007, 185:69-75.
14. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 1999, 23:743-760.
15. Fendt M., Imobersteg S., Bürki H., McAllister K.H., Sailer A.W. Intra-amygdala injections of neuropeptide S block fear-potentiated startle. Neuroreport 2009.
16. Garakani A., Mathew S.J., Charney D.S. Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 2006, 73:941-949.
17. Garau C., Okamura N., Duangdao D.M., Reinscheid R.K. The role of neuropeptide S and its receptor in fear memory consolidation and extinction. Soc Neurosci Abstr 2009, 39. (881.14).
18. Jüngling K., Seidenbecher T., Sosulina L., Lesting J., Sangha S., Clark S.D., et al. Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 2008, 59:298-310.
19. Koch M. The neurobiology of startle. Prog Neurobiol 1999, 59:107-128.
20. Meis S., Bergado-Acosta J.R., Yanagawa Y., Obata K., Stork O., Munsch T. Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS ONE 2008, 3:e2695.
21. Misane I., Tovote P., Meyer M., Spiess J., Ogren S.O., Stiedl O. Time-dependent involvement of the dorsal hippocampus in trace fear conditioning in mice. Hippocampus 2005, 15:418-426.
22. Okamura N., Habay S.A., Zeng J., Chamberlin A.R., Reinscheid R.K. Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. J Pharmacol Exp Ther 2008, 325:893-901.
23. Okamura N., Hashimoto K., Iyo M., Shimizu E., Dempfle A., Friedel S., et al. Gender-specific association of a functional coding polymorphism in the neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 2007, 31:1444-1448.
24. Okamura N., Reinscheid R.K., Neuropeptide S. A novel modulator of stress and arousal. Stress 2007, 10:221-226.
25. Paneda C., Huitron-Resendiz S., Frago L.M., Chowen J.A., Picetti R., de Lecea L., et al. Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice. J Neurosci 2009, 29:4155-4161.
26. Pare D., Quirk G.J., LeDoux J. New vistas on amygdala networks in conditioned fear. J Neurophysiol 2004, 92:1-9.
27. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego.
28. Raczka KA, Gartmann N, Mechias M-L, Reif A, Büchel C, Deckert J, Kalisch R. A neuropeptide S receptor variant associated with overinterpretation of fear reactions: a potential neurogenetic basis for catastrophizing. Mol Psychiatry; in press.
29. Reinscheid R.K. Neuropeptide S: anatomy, pharmacology, genetics and physiological functions. Results Probl Cell Differ 2008, 46:145-158.
30. Rizzi A., Vergura R., Marzola G., Ruzza C., Guerrini R., Salvadori S., et al. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol 2008, 154:471-479.
31. Smith K.L., Patterson M., Dhillo W.S., Patel S.R., Semjonous N.M., Gardiner J.V., et al. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 2006, 147:3510-3518.
32. Vitale G., Filaferro M., Ruggieri V., Pennella S., Frigeri C., Rizzi A., et al. Anxiolytic-like effect of neuropeptide S in the rat defensive burying. Peptides 2008, 29:2286-2291.
33. Walker D., Yang Y., Ratti E., Corsi M., Trist D., Davis M. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsychopharmacology 2009, 34:1533-1542.
34. Xu Y.L., Gall C.M., Jackson V.R., Civelli O., Reinscheid R.K. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 2007, 500:84-102.
35. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z.W., Lin S.H., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 2004, 43:487-497.